RxDoctor Payments Data

Lien Tran, PA

Physician Assistant · El Monte, CANPI 1841798410

Payments from drug & device makers

$1,000in general payments, 2019–2025

Across 46 payments — averaging $21.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$168
  • Exact Sciences$146
  • Viiv Healthcare Company$125
  • Dexcom, Inc.$112
  • Novo Nordisk$74
  • Sanofi Pasteur Inc.$70
  • plus $305 from 11 others

What the payments were for

  • Food & beverage$1,000100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,000 in reported general payments places this provider in the 70th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Medicare billing

Part B allowed, 2024
$2,633
Medicare patients
26
Services billed
31

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin82$64,825
Evenity (2 Syringes)Romosozumab-Aqqg14$32,950
JanuviaSitagliptin Phosphate27$25,752
ProliaDenosumab15$23,867
Repatha SureclickEvolocumab32$23,140
KerendiaFinerenone27$22,482
JanumetSitagliptin Phos/Metformin Hcl29$21,074
OzempicSemaglutide20$18,057
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog36$10,766
RybelsusSemaglutide11$9,954
FarxigaDapagliflozin Propanediol14$9,703
BrilintaTicagrelor16$6,885
Breo ElliptaFluticasone/Vilanterol14$5,712
SteglatroErtugliflozin Pidolate15$5,045
VascepaIcosapent Ethyl14$4,968

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenEvenity (2 Syringes), Prolia$16$56,81629 claims
Novo NordiskOzempic, Rybelsus$74$28,01031 claims
BayerKerendia$19$22,48227 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 10,423 physician assistant providers in California.

Other physician assistant in El Monte

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →